Results 211 to 220 of about 48,370 (295)

Serum Soluble Urokinase-Type Plasminogen Activator Receptor: A Promising Biomarker for Stable Chronic Obstructive Pulmonary Disease Patients. [PDF]

Cureus
D R, Johnson P, Das S, Gr S.
europepmc   +1 more source

Urokinase-Type Plasminogen Activator Enhances the Neuroprotective Activity of Brain-Derived Neurotrophic Factor in a Model of Intracerebral Hemorrhage. [PDF]

Biomedicines, 2022
Dzhauari S, Litvinova S, Efimenko A, Aleksandrushkina N, Basalova N, Abakumov M, Danilova N, Malkov P, Balabanyan V, Bezuglova T, Balayants V, Mnikhovich M, Gulyaev M, Skryabina M, Popov V, Stambolsky D, Voronina T, Tkachuk V, Karagyaur M.   +18 more
europepmc   +1 more source

Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-Isoquinolinylguanidines

, 2004
Chris Barber, Roger P. Dickinson, Paul V. Fish   +2 more
openalex   +1 more source

Prognostic and Predictive value of the Urokinase-Type Plasminogen Activator (uPA) and Its Inhibitors PAI-1 and PAI-2 in Operable Breast Cancer [PDF]

, 2003
Tanja Čufer, Simona Borštnar, Ivan Vrhovec   +2 more
openalex   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor and Inflammatory Biomarker Response with Prognostic Significance after Acute Neuronal Injury - a Prospective Cohort Study. [PDF]

Inflammation
Sajanti A, Hellström S, Bennett C, Srinath A, Jhaveri A, Cao Y, Takala R, Frantzén J, Koskimäki F, Falter J, Lyne SB, Rantamäki T, Posti JP, Roine S, Jänkälä M, Puolitaival J, Kolehmainen S, Girard R, Rahi M, Rinne J, Castrén E, Koskimäki J.   +21 more
europepmc   +1 more source

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients. [PDF]

Sci Rep, 2022
Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Friborg J, Kjaer A.   +7 more
europepmc   +1 more source

Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis. Comparison with urokinase-induced coronary thrombolysis.

, 1987
Takashi Susawa, Yoshiki Yui, Ryuichi Hattori, Mamoru Takahashi, Takeshi Aoyama, Yoshiki Takatsu, Keiji Sakaguchi, Natsuko Yui, Chuichi Kawai   +8 more
openalex   +2 more sources

Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor. [PDF]

J Pers Med, 2022
Śmiłowska K, Śmiłowski M, Partyka R, Kokocińska D, Jałowiecki P.   +4 more
europepmc   +1 more source

Inactivation of urokinase-type plasminogen activator receptor induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice closely mimicking human systemic sclerosis

, 2014
Mirko Manetti, Irene Rosa, Anna Franca Milia, Dalila Conte, Martina Ruffo, Peter Carmeliet, Marco Matucci‐Cerinic, Lidia Ibba‐Manneschi   +7 more
openalex   +1 more source

Periodontal Clinicoradiographic Status and Whole Saliva Soluble Urokinase Plasminogen Activation Receptor and Tumor Necrosis Factor Alpha Levels in Type-2 Diabetic and Non-diabetic Individuals.

, 2021
Dena Ali, Sayed Saad Qasem, Jagan Kumar Baskaradoss   +2 more
openalex   +2 more sources